RELA and neoplasm: While downregulation of RelA/p65 did not affect the proliferation of the human lung cancer cells grown as monolayers in vitro, it was required for their tumour growth in vivo grown as xenografts in immune-compromised mice (Figure 1), suggesting that RelA/p65 functions in lung epithelial cells as an NSCLC tumour promoter.